Yantai Zhenghai Biotechnology Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Kan Song

Chief Executive Officer (CEO)

CN¥1.1m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	1.9yrs
Participación del CEO	n/a
Permanencia media de la dirección	4.6yrs
Promedio de permanencia en la Junta Directiva	5.2yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Kan Song (41 yo)

1.9yrs

Permanencia

CN¥1,116,100

Compensación

Mr. Kan Song is Chairman since April 12, 2023 & General Manager and Director of Yantai Zhenghai Biotechnology Co., Ltd. from January 06, 2023. He is Secretary of Yantai Zhenghai Biotechnology Co., Ltd sinc...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kan Song	GM, Secretary & Chairman	1.9yrs	CN¥1.12m	sin datos
Li Zhao	Deputy GM	no data	CN¥904.90k	sin datos
Xing Yang	Deputy General Manager	4.6yrs	CN¥1.52m	sin datos
Donggang Zhang	Deputy General Manager	7.3yrs	CN¥907.90k	sin datos

4.6yrs

Permanencia media

46.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 300653 se considera experimentado (4.6 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kan Song	GM, Secretary & Chairman	1.8yrs	CN¥1.12m	sin datos
Li Zhao	Deputy GM	4.5yrs	CN¥904.90k	sin datos
Dong Qun	Vice Chairman	9.4yrs	sin datos	sin datos
Chao Zhang	Non-Independent Director	6.6yrs	sin datos	sin datos
Weiguo Jiang	Non-Independent Director	5.2yrs	sin datos	sin datos
Hui Xu	Independent Director	3.6yrs	CN¥60.00k	sin datos
Xiliang Song	Independent Director	3.6yrs	CN¥60.00k	sin datos
Landing Zhang	Independent Director	3.6yrs	CN¥60.00k	sin datos
Yueli Xu	Chairman of the Supervisory Board	9.4yrs	sin datos	sin datos
Lishan Pan	Non-Employee Supervisor	5.2yrs	sin datos	sin datos
Lei Zhao	Employee Supervisor	9.4yrs	sin datos	sin datos

5.2yrs

Permanencia media

49yo

Promedio de edad

Junta con experiencia: La junta directiva de 300653 se considera experimentada (5.2 años de antigüedad promedio).

Yantai Zhenghai Biotechnology Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Yantai Zhenghai Biotechnology Co., Ltd., Annual General Meeting, Apr 22, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.21 in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

New major risk - Share price stability

Yantai Zhenghai Biotechnology Co., Ltd. to Report Q3, 2024 Results on Oct 23, 2024

Investor sentiment improves as stock rises 16%

Now 22% overvalued

Now 20% overvalued

Investor sentiment deteriorates as stock falls 17%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.31 in 2Q 2023)

Yantai Zhenghai Biotechnology Co., Ltd. to Report First Half, 2024 Results on Aug 06, 2024

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 14 June 2024

Investor sentiment improves as stock rises 17%

First quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.30 in 1Q 2023)

Yantai Zhenghai Biotechnology Co., Ltd., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings released: EPS: CN¥1.06 (vs CN¥1.28 in FY 2022)

Yantai Zhenghai Biotechnology Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Investor sentiment deteriorates as stock falls 15%

Yantai Zhenghai Biotechnology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 02, 2024

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.28 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.31 (vs CN¥0.27 in 2Q 2022)

Yantai Zhenghai Biotechnology Co., Ltd. to Report First Half, 2023 Results on Aug 01, 2023

Yantai Zhenghai Biotechnology Co., Ltd. Implements Final Cash Dividend of 10 A Shares for 2022, Payable on May 30, 2023

Now 29% undervalued after recent price drop

Full year 2022 earnings released: EPS: CN¥1.28 (vs CN¥0.93 in FY 2021)

Full year 2022 earnings released: EPS: CN¥1.01 (vs CN¥0.93 in FY 2021)

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.25 in 3Q 2021)

Investor sentiment improved over the past week

Now 26% undervalued after recent price drop

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.27 (vs CN¥0.21 in 2Q 2021)

Investor sentiment improved over the past week

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2021, Payable on May 19, 2022

High number of new and inexperienced directors

First quarter 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.37 in 1Q 2021)

Yantai Zhenghai Biotechnology Co., Ltd. Proposes Distribution for 2021

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.37 (vs CN¥0.34 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.31 (vs CN¥0.30 in 2Q 2020)

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on May 20, 2021

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.37 (vs CN¥0.16 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.99 (vs CN¥0.89 in FY 2019)

New 90-day low: CN¥45.02

New 90-day low: CN¥49.35

New 90-day low: CN¥52.20

New 90-day low: CN¥57.91

New 90-day low: CN¥61.00

Third quarter earnings released

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad